Hospital Universitari Vall d'Hebrón

Barcelona, Catalonia 8035

0 studies enrolling now · 2 studies all time

What they study most

Advanced Lung Cancer, Cervical Carcinoma, Endometrial Carcinoma, Fallopian Tube Carcinoma, Lung Cancer, Metastatic Lung Cancer, NSCLC, Non-Small Cell Lung Cancer, Ovarian Carcinoma, Primary Peritoneal Carcinoma, SCLC, Small Cell Lung Cancer

Studies at this site

• Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) — Status unconfirmed
• A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations — Stopped early